Anticancer agent 232

• UNSPSC Description:

  Anticancer agent 232 (compound 12f) is a glycohybrid designed using 1-azidoglycosides derived from d-glucose, d-galactose, and d-mannose. The IC50 values ​​of anticancer agent 232 against MCF-7 and MDA-MB231 cells are 1.05 μM and 18.03 μM, respectively[1].

• Target Antigen:

  Endogenous Metabolite

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/anticancer-agent-232.html

• Smiles:

  O=C(C1=CC=CO1)/C=C/C2=CN(CC3=CN([C@H]4O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@H]4OC(C)=O)N=N3)C5=CC=C(Br)C=C52

• Molecular Weight:

  727.51

• References & Citations:

  [1]Tyagi R,et al. Efficient synthesis of indole-chalcones based glycohybrids and their anticancer activity. Bioorg Med Chem. 2024 Jul 15;109:117778.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  9007-83-4